Your search returned 24 results. Subscribe to this search

Not what you expected? Check for suggestions
|
1. Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach

by Patil V | Noronha V | Joshi A | Deodhar J | Goswami S | Chakraborty S | Ramaswamy A | Dhumal S | Chandrakanth MV | Karpe A | Pande N | Talreja V | Chandrasekharan A | Turkar S | Prabhash K [Corresponding author].

In Journal of Global Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

2. Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

by Joshi A | Joshi A | Patil V | Noronha V | Chougule A | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding author].

In Lung India
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

3. Efficacy of Gefitinib in Epidermal Growth Factor Receptor-Activating Mutation-Positive Nonsmall Cell Lung Cancer: Does Exon 19 Deletion Differ from Exon 21 Mutation?

by Joshi A | Patil V | Noronha V | Chougule A | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding Author].

In Lung India
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

4. Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

by Joshi A | Noronha V | Patil VM | Chougule A | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K.

In Chemotherapy Research and Practice
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

5. Expectations and preferences for palliative chemotherapy in head and neck cancers patients

by Patil V | Prabhash K | Ramaswamy A | Turkar S | Chandrasekharan A | Talreja V | Karpe A | Chandrakanth M | Dhumal S | Bhattacharjee A | Deodhar J | Noronha V | Joshi A.

In Oral Oncology
Material type: article Article Publisher: Amsterdam Elsevier 2016Online access: Click here to access online Availability: Items available for loan: Tata Memorial Hospital (1).

6. Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

by Noronha V | Patil V | Joshi A | Chougule A | Bhattacharjee A | Kumar R | More S | Goud S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K.

In Ecancermedicalscience
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

7. Influence of Hypothyroidism After Chemoradiation on Outcomes in Head and Neck Cancer.

by Patil VM | Noronha V | Joshi A | Bhattacharjee A | Goel A | Talreja V | Chandrasekharan A | Pande N | Mandal T | Ramaswamy A | Prabhash K [Corresponding author].

In Clinical Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

8. Metronomic palliative chemotherapy in maxillary sinus tumor.

by Patil VM | Noronh V | Joshi A | Karpe A | Talreja V | Chandrasekharan A | Dhumal S | Prabhash K [Corresponding author].

In South Asian Journal of Cancer
Material type: article Article; Format: print Publisher: Mumbai : Medknow Publications and Media Pvt. Ltd. 2016Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

9. Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.

by Noronha V | Joshi A | Patil VM | Agarwal J | Ghosh-Laskar S | Budrukkar A | Murthy V | Gupta T | D'Cruz AK | Banavali S | Pai PS | Chaturvedi P | Chaukar D | Pande N | Chandrasekharan A | Talreja V | Vallathol DH | Mathrudev V | Manjrekar A | Maske K | Bhelekar AS | Nawale K | Kannan S | Gota V | Bhattacharjee A | Kane S | Juvekar SL | Prabhash K [Corresponding Author].

In Journal of Clinical Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

10. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.

by Bajpai J [Corresponding author] | Chandrasekharan A | Talreja V | Simha V | Chandrakanth MV | Rekhi B | Khurana S | Khan A | Vora T | Ghosh J | Banavali SD | Gupta S.

In European Journal of Cancer
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

11. Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non-High-Dose Methotrexate-Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center.

by Bajpai J [Corresponding author] | Chandrasekharan A | Simha V | Talreja V | Karpe A | Pandey N | Singh A | Rekhi B | Vora T | Ghosh J | Banavali S | Gupta S.

In Journal of Global Oncology.
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

12. P3.02b-007 Differential Efficacy of Gefitinib in Exon 19 or Exon 21 Mutated Adenocarcinoma Lung

by Goel A | Joshi A | Patil V | Noronha V | Chougule A | Mahajan A | Janu A | Kaushal R | Goud S | More S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Talreja V | Chanana R | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

13. P3.02b-055 Impact of pemetrexed chemotherapy in exon 19 or exon 21 mutated nsclc

by Talreja V | Noronha V | Patil V | Joshi A | Chougule A | Mahajan A | Janu A | Goud S | More S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Goel A | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York, NY : Elsevier 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

14. P3.02b-058 Second-Line Therapy in EGFR Activating Mutation Positive Advanced NSCLC: Analysis from a Randomized Phase III First-Line Trial

by Ramaswamy A | Patil V | Joshi A | Noronha V | Choughule A | Mahajan A | Goud S | More S | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

15. Palliative chemotherapy in carcinoma nasopharynx

by Patil VM | Joshi A | Noronha V | Talreja V | Simha V | Dhumal S | Bandekar B | Chandrasekharan A | Kumar Prabhash [Corresponding Author].

In South Asian Journal of Cancer
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

16. Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer

by Patil VM | Noronha V | Joshi A | Dhumal S | Mahimkar M | Bhattacharjee A | Gota V | Pandey M | Menon N | Mahajan A | Sable N | Kumar S | Nawale K | Mukadam S | Solanki B | Das S | Simha V | Abraham G | Chandrasekharan A | Talreja V | DSouza H | Srinivas S | Kashyap L | Banavali S | Prabhash K [Corresponding Author].

In Journal of Clinical Oncology
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

17. Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

by Patil VM | Noronha V | Joshi A | Choughule AB | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding author].

In ESMO Open
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

18. PUB118 Pre-chemotherapy EGFR mutation status & outcomes with second line gefitinib in advanced adenocarcinoma lung

by Karpe A | Noronha V | Patil V | Joshi A | Chougule A | Janu A | More S | Goud S | Ramaswamy A | Pande N | Chandrasekharan A | Goel A | Talreja V | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York: Elsevier 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

19. Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/ carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer

by Patil V | Noronha V | Joshi A | Chougule A | Bhattacharjee A | Goel A | Talreja V | Menon N | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Mahajan A | Janu A | Purandare N | Kumar P [Corresponding Author].

In Cancer Research, Statistics, and Treatment
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

20. Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

by Patil V | Joshi A | Noronha V | Bhattacharjee A | Dhumal S | Chandrakanth MV | Karpe A | Talreja V | Chandrasekharan A | Turkar S | Pande N | Ramaswamy A | Prabhash K [Corresponding author].

In South Asian Journal of Cancer
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

Powered by Koha